GioTag: Real-world data study on sequential therapy with Gi(l)otrif®/ afatinib as first-line treatment followed by osimertinib in patients with EGFR mutation positive advanced non-small cell lung cancer First published 29/09/2017 Last updated 02/07/2024 EU PAS number:EUPAS21037 Study Finalised